<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04828642</url>
  </required_header>
  <id_info>
    <org_study_id>CIPI/20/209</org_study_id>
    <nct_id>NCT04828642</nct_id>
  </id_info>
  <brief_title>Antioxidant Vitaminas and Hypertrophy Adaptations to Resistance Training</brief_title>
  <official_title>Vitamins C and Vitamin E and Hypertrophy Adaptations to Resistance Traini</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigations aims to investigate whether supplementation with antioxidant vitamins&#xD;
      (vitamin C and vitamin E) can influence, enhancing or blocking, the hypertrophic adaptations&#xD;
      caused by strength training in sedentary subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double-blind, placebo-control controlled trial will be conducted. In a previous&#xD;
      session volunteers will be interviewed to determine if they meet the inclusion criteria. Will&#xD;
      be done two weeks of flushing out other types of supplementation and strenuous physical&#xD;
      exercise, along with familiarization with the strength training program and performance tests&#xD;
      to be carried out during the rehearsal. Subsequently, it will be a week without exercising to&#xD;
      start with the experimental designs. From the start of the trial, participants should avoid&#xD;
      physical exercise. strenuous outside the training protocol and if usual, they will only be&#xD;
      able to perform one resistance training session per week. Participants should avoid ingesting&#xD;
      of foods that contain high amounts of antioxidant compounds: more than two juices of fruits,&#xD;
      more than four cups of coffee or tea. Juices with high antioxidant content should be avoided.&#xD;
      Alcoholic beverages should also be avoided.&#xD;
&#xD;
        -  Group 1 (G1): Antioxidant vitamins (VitC (1000 mg) + VitE (235 mg)) + exercise&#xD;
&#xD;
        -  Group 2 (G2): Placebo + exercise A supplementation period of 12 weeks will be carried&#xD;
           out. In each period, supplementation with antioxidant vitamins: VitC (1000 mg) + VitE&#xD;
           (235 mg) or with placebo.&#xD;
&#xD;
      All participants will ingest the supplementation between 1-3 hours before training, the days&#xD;
      of rest in the mornings.&#xD;
&#xD;
      All participants will perform a 12-week strength training protocol. The training session&#xD;
      performed in the sharp design will be the first training session in chronic design. Being the&#xD;
      baseline (E0) and post-exercise (E1) assessment performed in G1, G2 and G3 also the first&#xD;
      evaluation corresponding to the chronic design.&#xD;
&#xD;
      In the middle of the supplementation period (week 6) and at the end, two new evaluations&#xD;
      (week 12). Baseline evaluations will be performed prior to an exercise session of week 6 (E2)&#xD;
      and at the last exercise session (E3) of the following parameters: performance physique, body&#xD;
      composition, micronutrient analysis, muscle ultrasound. I also know conduct post-exercise&#xD;
      physical performance assessments Figure 2.&#xD;
&#xD;
      The strength training protocol will be carried out 4 days a week at the facilities sports of&#xD;
      the European University. The sessions will be planned by a professional from the Sciences of&#xD;
      Physical Activity and Sports. Sessions will be tracked through a diary.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized, double-blind, placebo-control, parallel controlled trial will be conducted.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>The provider will produce the supplementation and the placebo with the same aspect, marked with numbers</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>DEXA</measure>
    <time_frame>Week 0</time_frame>
    <description>Evaluation of muscle mass with dual energy X-ray absorptiometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DEXA</measure>
    <time_frame>Week 10</time_frame>
    <description>Evaluation of muscle mass with dual energy X-ray absorptiometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>Week 0</time_frame>
    <description>Evaluation of muscle mass by a ISAK 1 level anthropometrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>Week 5</time_frame>
    <description>Evaluation of muscle mass by a ISAK 1 level anthropometrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>Week 10</time_frame>
    <description>Evaluation of muscle mass by a ISAK 1 level anthropometrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bioimpedance</measure>
    <time_frame>Week 0</time_frame>
    <description>Evaluation of muscle mass with an Inbody</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bioimpedance</measure>
    <time_frame>Week 5</time_frame>
    <description>Evaluation of muscle mass with an Inbody</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bioimpedance</measure>
    <time_frame>Week10</time_frame>
    <description>Evaluation of muscle mass with an Inbody</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DOMS</measure>
    <time_frame>Week 0</time_frame>
    <description>Delayed onset muscle soreness evaluated with visual analoguic scale (0 no pain- 10 maximal pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DOMS</measure>
    <time_frame>Week 5</time_frame>
    <description>Delayed onset muscle soreness evaluated with visual analoguic scale (0 no pain- 10 maximal pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DOMS</measure>
    <time_frame>Week 10</time_frame>
    <description>Delayed onset muscle soreness evaluated with visual analoguic scale (0 no pain- 10 maximal pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Manual dinamometry</measure>
    <time_frame>Week 0</time_frame>
    <description>Handgrip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Manual dinamometry</measure>
    <time_frame>Week 5</time_frame>
    <description>Handgrip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg dinamometry</measure>
    <time_frame>Week 0</time_frame>
    <description>Dinamometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg dinamometry</measure>
    <time_frame>Week 5</time_frame>
    <description>Dinamometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg dinamometry</measure>
    <time_frame>Week 10</time_frame>
    <description>Dinamometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RPE</measure>
    <time_frame>Week 0</time_frame>
    <description>10-point scale (no exertion 0- maximal effort 10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RPE</measure>
    <time_frame>Week 5</time_frame>
    <description>10-point scale (no exertion 0- maximal effort 10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RPE</measure>
    <time_frame>Week 10</time_frame>
    <description>10-point scale (no exertion 0- maximal effort 10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1 RM</measure>
    <time_frame>Week 0</time_frame>
    <description>Bench press and squats</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1 RM</measure>
    <time_frame>Week 5</time_frame>
    <description>Bench press and squats</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1 RM</measure>
    <time_frame>Week 10</time_frame>
    <description>Bench press and squats</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parameters determined by ENCODER</measure>
    <time_frame>Week 0</time_frame>
    <description>Bench press and squats</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parameters determined by ENCODER</measure>
    <time_frame>Week 5</time_frame>
    <description>Bench press and squats</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parameters determined by ENCODER</measure>
    <time_frame>Week 10</time_frame>
    <description>Bench press and squats</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hypertrophy</condition>
  <arm_group>
    <arm_group_label>Supplementation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antioxidant vitamins (Vitamin C (1000 mg) + Vitamine E (235 mg))</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo supplementation with the same aspect as supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C and vitamin E</intervention_name>
    <description>1000 mg 235 mg</description>
    <arm_group_label>Supplementation group</arm_group_label>
    <other_name>Ascorbic acid and tocopherol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Experience in strength training of at least one year&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Antioxidant supplementation&#xD;
&#xD;
          -  Injuries or diseases&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidad Europea de Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Dutra MT, Martins WR, Ribeiro ALA, Bottaro M. The Effects of Strength Training Combined with Vitamin C and E Supplementation on Skeletal Muscle Mass and Strength: A Systematic Review and Meta-Analysis. J Sports Med (Hindawi Publ Corp). 2020 Jan 8;2020:3505209. doi: 10.1155/2020/3505209. eCollection 2020. Review.</citation>
    <PMID>31970196</PMID>
  </reference>
  <results_reference>
    <citation>Dutra MT, Alex S, Mota MR, Sales NB, Brown LE, Bottaro M. Effect of strength training combined with antioxidant supplementation on muscular performance. Appl Physiol Nutr Metab. 2018 Aug;43(8):775-781. doi: 10.1139/apnm-2017-0866. Epub 2018 Jun 25.</citation>
    <PMID>29939770</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>August 1, 2021</last_update_submitted>
  <last_update_submitted_qc>August 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>María Martínez Ferrán</investigator_full_name>
    <investigator_title>predoctoral researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

